Office of Inspector General, U.S. Department of Health and Human Services

Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update

Retrieved on: 
Thursday, November 9, 2023
Cream, Female, FDA, Bacterial vaginosis, Research, Human development, Trial of the century, Cooperative research and development agreement, Vaginal discharge, Food, Hot, Organon, Human services, Eunice Kennedy Shriver National Institute of Child Health and Human Development, G&A, Progesterone, Phase 3, Quarter, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Call, Development, NICHD, Webcast, Clinical trial, ID, Tamoxifen, FSAD, Bacteria, Hormone, NIH, Woman, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Patient, Bangladesh Technical Education Board, Pharmaceutical industry, Birth control, Bayer, Conference

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update.

Key Points: 
  • ET
    SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update.
  • XACIATO™ provides a new therapeutic option for the millions of women suffering from bacterial vaginosis in the U.S.
  • Financial Highlights for the Quarter ended September 30, 2023
    Cash and cash equivalents: $13.8 million at September 30, 2023.
  • Daré will host a conference call and live webcast today, November 9, 2023, at 4:30 p.m. Eastern Time to review financial results for the quarter ended September 30, 2023 and to provide a company update.

Former DOJ Trial Attorney Michael Shaheen Returns to Crowell & Moring

Retrieved on: 
Thursday, November 9, 2023
Quinn Emanuel Urquhart & Sullivan, Stark Law, Cornell Law School, Government, United States Justice Department investigation into attempts to overturn the 2020 presidential election, Crowell & Moring, Justice minister, Lawyer, Risk, False Claims Act, White collar, Anti-Kickback Statute, Saolta University Health Care Group, Office of Inspector General, U.S. Department of Health and Human Services, FCA, Vanderbilt University, DOJ, Pharmaceutical industry

WASHINGTON, Nov. 9, 2023 /PRNewswire/ -- Michael Shaheen , former trial attorney in the U.S. Department of Justice Commercial Litigation Branch's Fraud Section, has rejoined Crowell & Moring.

Key Points: 
  • WASHINGTON, Nov. 9, 2023 /PRNewswire/ -- Michael Shaheen , former trial attorney in the U.S. Department of Justice Commercial Litigation Branch's Fraud Section, has rejoined Crowell & Moring.
  • Shaheen returns as a partner in the firm's Health Care Group where he will focus on False Claims Act cases and healthcare fraud and abuse.
  • While at the Justice Department, Shaheen's roles on False Claims Act cases ranged from lead investigator to first chair trial attorney.
  • He was an associate at an AmLaw 100 firm prior to joining the DOJ in 2014.

Honoring Our Nations Veterans: New Veterans Resources Guide Unveiled to Unlock Vital Benefits to Support Our Heroes at Life's End.

Retrieved on: 
Thursday, November 9, 2023
U.S. Department of Veterans Affairs, Office of Inspector General, Ageing, National Partnership, Health care, NPHI, SBP, Hospice, Caregiver, Defense Finance and Accounting Service, United States Department of Veterans Affairs, Palliative care, Office of Inspector General, U.S. Department of Health and Human Services, Patient, Veterans Day, Pay, Tuskegee Veterans Administration Medical Center, Hospital, Management, Veteran

These resources encompass not only those provided by the Veterans Administration but also vital state and local services.

Key Points: 
  • These resources encompass not only those provided by the Veterans Administration but also vital state and local services.
  • In addition, the guide offers insights into military pay, retirement pay, and survivor benefits, all administered through the Defense Finance and Accounting Services.
  • "The 'Serving Those Who Served Us' Veterans Resources Guide is a testament to NPHI's dedication to enhancing the lives of our Veterans," said Tom Koutsoumpas, NPHI CEO.
  • While the U.S. Department of Veterans Affairs (VA) provides a range of benefits for Veterans, many of these services are underutilized or difficult to access.

Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Retrieved on: 
Wednesday, November 8, 2023
PCV, SLATE, CORAL, FDA, Biomedical Advanced Research and Development Authority, Research, IND, Gritstone bio, NCI, Food, Health, Infection, Vaccine, Human services, National Institutes of Health Clinical Center, Administration for Strategic Preparedness and Response, HIV, Gates, BARDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, United States Department of Health and Human Services, Administration, Development, Gilead, NAB, Clinical trial, COVID-19, National Cancer Institute, Messenger, Collaboration, Immunotherapy, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, CEPI, Chemistry, Patient, Pharmaceutical industry, Gritstone, LNP

EMERYVILLE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today reported financial results for the third quarter ended September 30, 2023 and provided recent corporate and clinical updates.

Key Points: 
  • In oncology, preliminary findings from the randomized Phase 2/3 study of our personalized cancer vaccine, GRANITE, in MSS-CRC are rapidly approaching.
  • The scientific bedrock of GRANITE extends to SLATE, where our collaboration with Steven A. Rosenberg and the NCI is now advancing.
  • Gritstone met its enrollment target of 100 patients randomized in August 2023.
  • An IND to run a Phase 1 study was cleared by the U.S. Food and Drug Administration (FDA) in October 2023.

Battelle Part of Team Selected to Support New Technologies to Prepare for Future COVID-19 Outbreaks

Retrieved on: 
Wednesday, November 8, 2023
Engineering, Public Policy, Government, Chemicals, Plastics, Defense, Technology, Manufacturing, COVID-19, Pharmaceutical, Medical Devices, Infectious Diseases, Health Technology, Genetics, Science, Biotechnology, White House, Federal Government, Health, Other Technology, Other Science, Other Manufacturing, Research, Other Defense, Contracts, Biomedical Advanced Research and Development Authority, HHS, Autumn, Therapy, SARS-CoV-2, Battelle, Human services, Administration for Strategic Preparedness and Response, Project, BARDA, United States Department of Health and Human Services, Administration, ASPR, Development, Lung, MPS, Antibody, Nextgen, Messenger, IDIQ, Office of Inspector General, U.S. Department of Health and Human Services, Vaccine, Medical device

These technologies have the potential to enable shorter development timelines for monoclonal antibodies through mRNA, increased efficiency in virus testing, and alternate routes for vaccine administration.

Key Points: 
  • These technologies have the potential to enable shorter development timelines for monoclonal antibodies through mRNA, increased efficiency in virus testing, and alternate routes for vaccine administration.
  • Battelle researchers will develop a human lung microphysiological system (MPS) platform to enable in vitro modeling of SARS-CoV-2 infection and testing of therapeutics.
  • This complex in vitro model is expected to recapitulate relevant human lung biology, including viral pathogenesis and response to medical countermeasures.
  • The MPS model is expected to be established and ready for therapeutic screening in the Fall of 2025.

Intact Technology Appoints Bahar Niakan as Managing Director

Retrieved on: 
Wednesday, November 8, 2023
Professional Services, White House, Federal Government, Public Policy, Government, Technology, Human Resources, Software, Artificial Intelligence, OPM, Leadership development, HHS, ESM, Federal Executive Institute, Policy, Niakan, Organization, Federation, Intact, Office of Inspector General, U.S. Department of Health and Human Services, Multimedia, Health Resources and Services Administration, Public sector, Private sector, Partnership, Human, ServiceNow, HR, Public Works Management & Policy, Federal, Process, Culture, Lab, Presidential Management Fellows Program, AI, Improper integral, General counsel, Automation, Service, Management, Sales

Intact Technology, Inc., a leading Enterprise Service Management (ESM) firm, announces the appointment of Bahar Niakan as a Managing Director, HR Modernization effective immediately.

Key Points: 
  • Intact Technology, Inc., a leading Enterprise Service Management (ESM) firm, announces the appointment of Bahar Niakan as a Managing Director, HR Modernization effective immediately.
  • She joins Intact from the U.S. Office of Personnel Management (OPM) where she served as Deputy Associate Director, OPM Center for Leadership Development for the past two years.
  • She focused on optimizing HR service delivery, modernizing HR Information Technology, and improving the employee performance and engagement culture at HHS.
  • “Intact is dedicated to understanding customer needs and finding the best solution,” Niakan said.

STEPS ranks top colleges for online degrees in public service for 2024

Retrieved on: 
Wednesday, November 8, 2023
NCES, United States Secretary of Education, National Center for Women & Information Technology, Catalog, Psychology, IPEDS, Smith, School, Accreditation, National Center for Education Statistics, Quality of life, Student, University, Teaching, RENO, Social work, Public, Office of Inspector General, U.S. Department of Health and Human Services, Public service, Integration, Integrated Postsecondary Education Data System, Nursing, Tutoring, STEPS

RENO, Nev., Nov. 8, 2023 /PRNewswire-PRWeb/ -- STEPS, a trusted resource for connecting students with degrees and careers in public service, has released its college rankings for the 2023-2024 school year. The rankings feature colleges and universities with online degrees in subject areas focused on community health and improvement. Over 25 public service fields were ranked, including teaching, psychology, social work, public health and public administration.

Key Points: 
  • STEPS (Student Training & Education in Public Service) has identified the top U.S. colleges for online degrees in public service for 2024.
  • RENO, Nev., Nov. 8, 2023 /PRNewswire-PRWeb/ -- STEPS, a trusted resource for connecting students with degrees and careers in public service, has released its college rankings for the 2023-2024 school year.
  • The rankings feature colleges and universities with online degrees in subject areas focused on community health and improvement.
  • Over 25 public service fields were ranked, including teaching, psychology, social work, public health and public administration.

The Majority of K-12 Public Schools Offer Academically Focused Summer and After-School Programs

Retrieved on: 
Wednesday, November 8, 2023
NCES, United States Secretary of Education, National Center on Time & Learning, Policy, SPP, Sport, Education sciences, American Samoa, Recreation, U.S. Department of Education, Office of Inspector General, K-12, Organization, OA, National Center for Education Statistics, Research, Commonwealth, Learning, City, Capitol Hill, Saipan, Student, Employment, School, IES, Office of Inspector General, U.S. Department of Health and Human Services, Collection, Virgin Islands, ESSER, Elementary, Parent, Tutoring, Pharmaceutical industry, Tourism, Nursing, Education

WASHINGTON, Nov. 8, 2023 /PRNewswire/ -- Seventy-eight percent of U.S. public schools provided summer programming in 2023 designed to help students academically, according to data released today by the National Center for Education Statistics (NCES), the statistical center within the U.S. Department of Education's Institute of Education Sciences (IES).

Key Points: 
  • The NCES data on academically focused summer programs includes summer school, learning and enrichment (L&E), bridge, and other summer programs.
  • Seventy-eight percent offered academically focused summer programming, which includes summer school, learning and enrichment (L&E), bridge, and other summer programs.
  • Around 90 percent of public schools offering academically focused summer programs did so at no cost to families (summer school, 90 percent; L&E programs, 87 percent; bridge programs, 90 percent).
  • Most public schools offering academically focused summer programs had full-time teachers working in these programs (summer school, 95 percent; L&E programs, 89 percent; bridge programs, 86 percent).

The NYSPCC Receives $1.65 Million in Grants for Programs that Advance Agency's Mission to Prevent Child Abuse

Retrieved on: 
Tuesday, November 7, 2023
Knowledge, Supreme court, Woman, Domestic violence, New York Society for the Prevention of Cruelty to Children, Child, Gold, HHS, International Food Protection Training Institute, Survivor, NYSPCC, Health, Heart, OVW, Violence Against Women Act, Human services, Organization, Violence, Research, Trauma, Caregiver, Curriculum, Protective factor, Physical abuse, Violence against women, School, Nanjing Land and Visit Program, Office on Violence Against Women, NIH, Safety, Depression, Office of Inspector General, U.S. Department of Health and Human Services, United States Department of Health and Human Services, Anxiety, Randomized controlled trial, Bangladesh Technical Education Board, Parent, Nursing, New York University

NEW YORK, Nov. 7, 2023 /PRNewswire/ -- The New York Society for the Prevention of Cruelty to Children (NYSPCC), the world's first child protection agency, has received $1.65 million across three grants to help fund critical programs and services that further the agency's mission to respond to the complex needs of abused and neglected children.

Key Points: 
  • The grants come from the United States Department of Health and Human Services (HHS), the Office on Violence Against Women (OVW) and the National Institutes of Health (NIH).
  • For nearly 150 years, the NYSPCC has worked to protect children and those involved in their care by providing best-practice counseling, legal and educational services.
  • "To have been awarded such significant grants from key federal programs speaks volumes about the critical work the New York Society for the Prevention of Cruelty to Children does on behalf of children's safety.
  • Safe Touches is an evidence-based child sexual abuse prevention program designed for children in kindergarten through third grade.

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 7, 2023
Professional Services, Health, FDA, Finance, Clinical Trials, Pharmaceutical, Biotechnology, Biomedical Advanced Research and Development Authority, Research, Security (finance), NMPA, Therapy, Medication, Ganaxolone, SG, Human services, G&A, Marinus, Administration for Strategic Preparedness and Response, National Medical Products Administration, GAAP, Center for Drug Evaluation and Research, BARDA, MAD, Lennox–Gastaut syndrome, Administration, R, Development, RAISE, CDE, Epilepsy, RSE, API, TSC, NDA, U.S. Department of Defense Strategy for Operating in Cyberspace, Office of Inspector General, U.S. Department of Health and Human Services, Investment, Patient, Status epilepticus, Pharmaceutical industry, Fine chemical, Cryptocurrency, CDD

Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the third quarter ended September 30, 2023.
  • Dr. Braunstein continued, “We remain acutely focused on advancing our Phase 3 clinical trials in refractory status epilepticus and tuberous sclerosis complex.
  • Net product revenue consists of ZTALMY product sales, which was launched in the U.S. in the third quarter of 2022.
  • Selected Financial Data (in thousands, except share and per share amounts)